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Introduction

➢ Pancreatic divisum is the most common congenital
pancreatic anomaly affecting 10% of the Western
population. Failure of fusion of the ventral and dorsal
duct system with narrowing of the minor papillary
orifice makes the pancreas prone to injury due to
high intrapapillary dorsal ductal pressure
➢ Fewer than 5% are symptomatic with infrequent
bouts of pancreaticobiliary-type pain and even fewer
develop chronic pancreatitis or pseudocyst formation.
➢ Infrequently, hemorrhaging can cause pancreatic
pseudocysts to grow very large and become
extremely painful and life-threatening.

Case Presentation
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Figure 2. Hemorrhagic Pseudocyst of
Pancreatic Tail
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Figure 1. Anterior Abdominal Wall Pseudocyst

43-year-old Caucasian male with a history of alcoholinduced pancreatitis was admitted for abdominal pain,
nausea/emesis, and 13lb weight loss over two-week duration
He reported abstinence from alcohol for the past year with
recurrent pancreatic flairs managed conservatively in multiple
hospitalization
Labs revealed normal CA19-9, acute anemia (-8 Hgb) with no
overt evidence of bleed and CT yielding multiple large
pseudocysts: 22 x 10.8 cm hemorrhagic pancreatic pseudocyst
along the anterior abdominal wall (Figure 1), 16 x 18.9
cm heterogeneous cyst along the left anterolateral chest wall
(Figure 3), and 2.9 cm hemorrhagic pseudocyst at the tail of the
pancreas (Figure 2).
CT-angiogram revealed no active bleeding but marked pancreatic
duct dilation
Due to suspected pancreatic duct disruption, ERCP was performed
revealing pancreatic divisum and he underwent common bile and
pancreatic duct sphincterotomy without evidence of any stone
debris
Endoscopic-ultrasound for presumed pancreatic head mass was
unrevealing except for a large heterogeneous fluid
collection measuring 10 x 9 cm within the gastric body. FNA
yielded 5mL of sanguineous fluid.
The patient underwent cystogastrostomy with AXIOS stent
placement to drain the hemorrhagic pseudocyst into the stomach
and monitored within the ICU post-operatively.
He had self-limiting melena with no signs of infection and
improved general appearance with resolution of his abdominal
pain.
Follow-up imaging and EGD revealed complete collapse of the
pseudocyst with the decision for AXIOS stent removal
Patient is currently tolerating a low-fat diet with no recurrent
episodes of abdominal pain

Figure 3. Left Anterolateral Chest Wall Pseudocyst
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Figure 4. Endoscopic Cystgastrostomy Procedure with Axios Stent

Discussion

➢ This case illustrates a patient
with pancreatic divisum with recurrent bouts
of pancreatitis resulting in hemorrhagic pancreatic
pseudocysts formation with great outcome
to cystogastrostomy Axios stent placement.
➢ It is well-established that compromise
of pancreatic duct leads to recurrent pancreatic fluid
collections and severe outcomes. Observational studies
have postulated pancreatic divisum reduces the
threshold in developing pancreatic diseases such
as pseudocysts from known primary insults ie
alcohol, trauma, etc
➢ According to the Atlanta Classification 2012,
pseudocyst of the pancreas develops 4 weeks after the
development of acute pancreatitis. Infection, bleeding,
obstruction, and rupture are some of the complications
of pseudocyst of pancreas
➢ Hemorrhage into the pseudocyst occurs due to the
erosion of the arterial walls abutting the pseudocyst
due to the enzymatic action of the fluid present in the
pseudocyst. Splenic artery is most commonly
involved (30–50%), followed by the gastroduodenal
(17%) and pancreaticoduodenal arteries (11%)
➢ Hemorrhagic pseudocyst of pancreas carries a very
high mortality of 40%.
➢ Most pseudocyst are asymptomatic without further
treatment, while as symptomatic pseudocyst require
drainage
➢ Studies between endoscopic vs surgical drainage reveal
similar favorable outcomes, but endoscopic
techniques were associated with reduced hospital
length of stay and lower costs
➢ A combination of EUS/ERCP ductal sphincterotomy
and cystogastrostomy with stent placement may aid
cases with dual pancreatic divisum and hemorrhagic
pseudocystic formation
➢ Pancreatic hemorrhagic pseudocyst is an uncommon
but serious complication of recurrent pancreatitis, for
which pancreatic divisum should be in the differential
diagnosis
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